These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 27887864)

  • 1. Optimization of cGMP purification and expansion of umbilical cord blood-derived T-regulatory cells in support of first-in-human clinical trials.
    McKenna DH; Sumstad D; Kadidlo DM; Batdorf B; Lord CJ; Merkel SC; Koellner CM; Curtsinger JM; June CH; Riley JL; Levine BL; Miller JS; Brunstein CG; Wagner JE; Blazar BR; Hippen KL
    Cytotherapy; 2017 Feb; 19(2):250-262. PubMed ID: 27887864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cells.
    Hippen KL; Harker-Murray P; Porter SB; Merkel SC; Londer A; Taylor DK; Bina M; Panoskaltsis-Mortari A; Rubinstein P; Van Rooijen N; Golovina TN; Suhoski MM; Miller JS; Wagner JE; June CH; Riley JL; Blazar BR
    Blood; 2008 Oct; 112(7):2847-57. PubMed ID: 18645038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective role of functionalized single walled carbon nanotubes enhance ex vivo expansion of hematopoietic stem and progenitor cells in human umbilical cord blood.
    Bari S; Chu PP; Lim A; Fan X; Gay FP; Bunte RM; Lim TK; Li S; Chiu GN; Hwang WY
    Nanomedicine; 2013 Nov; 9(8):1304-16. PubMed ID: 23732300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance.
    Kim YJ; Broxmeyer HE
    Crit Rev Oncol Hematol; 2011 Aug; 79(2):112-26. PubMed ID: 20727784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methods of ex vivo expansion of human cord blood cells: challenges, successes and clinical implications.
    Baron F; Ruggeri A; Nagler A
    Expert Rev Hematol; 2016 Mar; 9(3):297-314. PubMed ID: 26635058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Umbilical cord blood-derived mesenchymal stromal cells promote myeloid-derived suppressor cell proliferation by secreting HLA-G to reduce acute graft-versus-host disease after hematopoietic stem cell transplantation.
    Yang S; Wei Y; Sun R; Lu W; Lv H; Xiao X; Cao Y; Jin X; Zhao M
    Cytotherapy; 2020 Dec; 22(12):718-733. PubMed ID: 32811747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Third-party umbilical cord blood-derived regulatory T cells prevent xenogenic graft-versus-host disease.
    Parmar S; Liu X; Tung SS; Robinson SN; Rodriguez G; Cooper LJ; Yang H; Shah N; Yang H; Konopleva M; Molldrem JJ; Garcia-Manero G; Najjar A; Yvon E; McNiece I; Rezvani K; Savoldo B; Bollard CM; Shpall EJ
    Cytotherapy; 2014 Jan; 16(1):90-100. PubMed ID: 24480547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressive Characteristics of Umbilical Cord Blood-derived Regulatory T Cells After Ex Vivo Expansion on Autologous and Allogeneic T Effectors and Various Lymphoblastic Cells.
    Vanichapol T; Pongsakul N; Srisala S; Apiwattanakul N; Chutipongtanate S; Hongeng S
    J Immunother; 2019 May; 42(4):110-118. PubMed ID: 30921263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging translational strategies and challenges for enhancing regulatory T cell therapy for graft-versus-host disease.
    Hippen KL; Hefazi M; Larson JH; Blazar BR
    Front Immunol; 2022; 13():926550. PubMed ID: 35967386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expansion of natural killer cell receptor (CD94/NKG2A)-expressing cytolytic CD8 T cells and CD4+CD25+ regulatory T cells from the same cord blood unit.
    Tanaka J; Sugita J; Kato N; Toubai T; Ibata M; Shono Y; Ota S; Kondo T; Kobayashi T; Kobayashi M; Asaka M; Imamura M
    Exp Hematol; 2007 Oct; 35(10):1562-6. PubMed ID: 17681668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-142-3p regulates autophagy by targeting ATG16L1 in thymic-derived regulatory T cell (tTreg).
    Lu Y; Gao J; Zhang S; Gu J; Lu H; Xia Y; Zhu Q; Qian X; Zhang F; Zhang C; Shen H; Hippen KL; Blazar BR; Lu L; Wang X
    Cell Death Dis; 2018 Feb; 9(3):290. PubMed ID: 29459719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid ex vivo expansion of highly enriched human invariant natural killer T cells via single antigenic stimulation for cell therapy to prevent graft-versus-host disease.
    Trujillo-Ocampo A; Cho HW; Herrmann AC; Ruiz-Vazquez W; Thornton AB; He H; Li D; Qazilbash MA; Ma Q; Porcelli SA; Shpall EJ; Molldrem J; Im JS
    Cytotherapy; 2018 Aug; 20(8):1089-1101. PubMed ID: 30076070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.
    Brunstein CG; Miller JS; Cao Q; McKenna DH; Hippen KL; Curtsinger J; Defor T; Levine BL; June CH; Rubinstein P; McGlave PB; Blazar BR; Wagner JE
    Blood; 2011 Jan; 117(3):1061-70. PubMed ID: 20952687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex vivo expansion and transplantation of hematopoietic stem/progenitor cells supported by mesenchymal stem cells from human umbilical cord blood.
    Huang GP; Pan ZJ; Jia BB; Zheng Q; Xie CG; Gu JH; McNiece IK; Wang JF
    Cell Transplant; 2007; 16(6):579-85. PubMed ID: 17912949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of bone marrow mesenchymal stem cells on hematopoietic recovery and acute graft-versus-host disease in murine allogeneic umbilical cord blood transplantation model.
    Li ZY; Wang CQ; Lu G; Pan XY; Xu KL
    Cell Biochem Biophys; 2014 Sep; 70(1):115-22. PubMed ID: 24696072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Good manufacturing practice-compliant isolation and culture of human umbilical cord blood-derived mesenchymal stem cells.
    Pham PV; Vu NB; Pham VM; Truong NH; Pham TL; Dang LT; Nguyen TT; Bui AN; Phan NK
    J Transl Med; 2014 Feb; 12():56. PubMed ID: 24565047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo expansion, maturation, and activation of umbilical cord blood-derived T lymphocytes with IL-2, IL-12, anti-CD3, and IL-7. Potential for adoptive cellular immunotherapy post-umbilical cord blood transplantation.
    Robinson KL; Ayello J; Hughes R; van de Ven C; Issitt L; Kurtzberg J; Cairo MS
    Exp Hematol; 2002 Mar; 30(3):245-51. PubMed ID: 11882362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo expansion of human umbilical cord blood does not lead to co-expansion of contaminating maternal mononuclear cells.
    Fietz T; Hilgenfeld E; Berdel WE; Hopp H; Wenzel U; Dohle W; Thiel E; Knauf WU
    Bone Marrow Transplant; 1997 Dec; 20(12):1019-26. PubMed ID: 9466273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanded umbilical cord blood T cells used as donor lymphocyte infusions after umbilical cord blood transplantation.
    Berglund S; Gertow J; Uhlin M; Mattsson J
    Cytotherapy; 2014 Nov; 16(11):1528-1536. PubMed ID: 25231890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution.
    Brown JA; Boussiotis VA
    Clin Immunol; 2008 Jun; 127(3):286-97. PubMed ID: 18395491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.